Founder of Clarkson lab at Cardiff University which has identified two genes that affect the spread of cancer.

Discovery and pre-clinical development of new anticancer drugs targeting advanced and metastatic disease and Independent Board Member of Velindre University NHS Trust.

Working from basic virology to translational oncology, involving the manipulation and engineering of adenoviruses into advanced therapeutic agents for the treatment of cancers.

Specialising in immunology and co-founder of the Gallimore Godkin lab which takes basic research using model systems of cancer through to testing novel immunotherapies in patients with cancer.